New hope for tough lung cancer: drug combo targets liver spread
Disease control
Recruiting now
This study tests whether adding the drug bevacizumab to standard chemo-immunotherapy can help people with extensive-stage small cell lung cancer that has spread to the liver. About 39 participants will receive the combination for up to a year. The goal is to see if it delays canc…
Phase: PHASE2 • Sponsor: Kamya Sankar • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC